Experience of using Artro-Patch in the stage II knee osteoarthritis treatment and the need for prior aspiration of arthritic fluid

Authors

  • Petro Zhuk National Pirogov Memorial Medical University, Vinnytsia
  • Maksym Matsipura National Pirogov Memorial Medical University, Vinnytsia

DOI:

https://doi.org/10.31636/prmd.v5i2.2

Keywords:

knee osteoarthritis, hyaluronic acid, degenerative-dystrophic diseases, gonarthrosis, WOMAC

Abstract

Considering the high frequency of degenerative-dystrophic diseases of the joints and the constant growth of morbidity, the improvement of treatment conservative approaches is an urgent task of modern medicine.

Background: to evaluate the effectiveness of using Artro-Patch (3 % hyaluronic acid solution, 3 ml) in patients with stage II knee osteoarthritis and the need to perform preliminary aspiration of arthritic fluid before intraarticular injection.

Materials and methods. 60 patients with stage II knee osteoarthritis who were treated with the use of Artro-Patch (3 % hyaluronic acid solution, 3 ml) were examined. The average age is 45.56 ± 8.61 years. The group includes 38 (63.33 %) women and 22 (36.67 %) men. Among them 2 groups were formed. Patients of group 1 (n = 30) received intra-articular injection of Artro-Patch. Patients of group 2 (n = 30) were injected with Artro-Patch with prior aspiration of arthritic synovial fluid. Clinical outcomes were assessed using the WOMAC questionnaire at admission, 30 days, and 90 days after the procedure. The StatSoft STATISTICA 13 program was used for statistical analysis. The probability of an error-free forecast was set at p < 0.05.

Results. As a result of using Artro-Patch in patients with stage II knee osteoarthritis, it was possible to achieve a reliable improvement of all clinical indicators determined by the WOMAC questionnaire. It has been proven that performing a preliminary aspira-tion of arthritic fluid before intra-articular injection of Artro-Patch leads to the development of a more stable and better clinical result at 30 days, with subsequent positive dynamics up to 90 days of observation.

Conclusions. Thus, the high effectiveness of using Artro-Patch drug in the treatment of stage II knee osteoarthritis has been proven. To achieve a stable and better clinical result, it is recommended to perform a preliminary aspiration of arthritic fluid before intra-articular injection of the drug.

Downloads

Download data is not yet available.

References

Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA [Internet]. 2021;325(6):568-578. Available from: https://doi.org/10.1001/jama.2020.22171

Ebell MH. Osteoarthritis: Rapid Evidence Review. Am Fam Physician [Internet]. 2018;97(8):523-526. Available from: https://pubmed.ncbi.nlm.nih.gov/29671497

Lopa S, Colombini A, Moretti M, de Girolamo L. Injective mesenchymal stem cell-based treatments for knee osteoarthritis: from mechanisms of action to current clinical evidences. Knee Surg Sports Trau-matol Arthrosc [Internet]. 2019;27(6):2003-2020. Available from: https://doi.org/10.1007/s00167-018-5118-9

Van Genechten W, Vuylsteke K, Martinez PR, Swinnen L, Sas K, Verdonk P. Autologous Micro-Fragmented Adipose Tissue (MFAT) to Treat Symptomatic Knee Osteoarthritis: Early Outcomes of a Consec-utive Case Series. J Clin Med [Internet]. 2021;10(11):2231. Published 2021 May 21. Available from: https://doi.org/10.3390/jcm10112231

Deshpande BR, Katz JN, Solomon DH, et al. Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity. Arthritis Care Res (Hoboken)[Internet]. 2016;68(12):1743-1750. Available from: https://doi.org/10.1002/acr.22897

Evans JT, Walker RW, Evans JP, Blom AW, Sayers A, Whitehouse MR. How long does a knee replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up [published correction appears in Lancet. 2019 Feb 20;:]. Lancet [Internet]. 2019;393(10172):655-663. Available from: https://doi.org/10.1016/S0140-6736(18)32531-5

Barfod KW, Blønd L. Treatment of osteoarthritis with autologous and microfragmented adipose tissue. Dan Med J [Internet]. 2019;66(10):A5565. Available from:https://pubmed.ncbi.nlm.nih.gov/31571571

Deshpande BR, Katz JN, Solomon DH, et al. Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity. Arthritis Care Res (Hoboken). 2016;68(12):1743-1750. Available from: https://doi.org/10.1002/acr.22897

Levy DM, Petersen KA, Scalley Vaught M, Christian DR, Cole BJ. Injections for Knee Osteoarthritis: Corticosteroids, Viscosupplementation, Platelet-Rich Plasma, and Autologous Stem Cells. Arthroscopy [Internet]. 2018;34(5):1730-1743. Available from: https://doi.org/10.1016/j.arthro.2018.02.022

Danieli MV, Guerreiro JPF, Vimercati TA, Mendes PHF, Miyazaki PRTK, Cataneo DC. Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Chondral Injuries In Young Patients. Rev Bras Ortop (Sao Paulo) [Internet]. 2021;56(5):634-640. Published 2021 Apr 19. https://doi.org/10.1055/s-0041-1724075

Lin H, Sohn J, Shen H, Langhans MT, Tuan RS. Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing. Biomaterials [Internet]. 2019 May;203:96–110. Available from: https://doi.org/10.1016/j.biomaterials.2018.06.026

O’Neill TW, Felson DT. Mechanisms of Osteoarthritis (OA) Pain. Current Osteoporosis Reports [Internet]. 2018 Aug 28;16(5):611–6. Available from: https://doi.org/10.1007/s11914-018-0477-1

Leopoldino AO, Machado GC, Ferreira PH, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev [Internet]. 2019;2(2):CD013273. Available from: https://doi.org/10.1002/14651858.cd013273

Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage [Internet]. 2019;27(11):1578-1589. Available from: https://doi.org/10.1016/j.joca.2019.06.011

Kohn MD, Sassoon AA, Fernando ND. Classifications in Brief: Kell-gren-Lawrence Classification of Osteoarthritis. Clin Orthop Relat Res [Internet]. 2016;474(8):1886-1893. Available from: https://doi.org/10.1007/s11999-016-4732-4

Досвід використання препарату Artro-Patch у лікуванні гонартрозу II ступеня та необхідність попередньої аспірації артритичної рідини

Downloads

Published

2023-01-29

Issue

Section

Original article

How to Cite

1.
Experience of using Artro-Patch in the stage II knee osteoarthritis treatment and the need for prior aspiration of arthritic fluid. prmd [Internet]. 2023 Jan. 29 [cited 2024 Mar. 29];5(2):14-8. Available from: https://perioperative.org.ua/index.php/prtmdc/article/view/106